What it is
Plasma pen — also called plasma fibroblast — uses a small electrical arc between the device tip and the skin to deliver controlled superficial thermal injury. The arc never touches the skin directly; it ionizes the air above it and produces a focal point of heat that creates a tiny carbon crust at the surface. The body responds with contraction of the surrounding tissue and a dermal remodeling response.
Each treated point is small. A trained provider creates a pattern of points across the indication — most commonly the upper eyelid, the periocular area, or fine lines around the mouth. The pattern, spacing, and intensity determine the result.
This is a focal tool. It is good at small, well-defined areas where the goal is localized tightening. It is not the right tool for broader-area work — microneedling RF and DermiTight do that better, with less downtime.
How Dr. Brown approaches it
Plasma pen at Esvie is recommended selectively. The two indications where it earns its place are mild upper eyelid hooding in patients who want to avoid surgery and fine lines in areas where laser or microneedling underperform.
Skin type matters here more than with most procedures. Plasma pen carries a real risk of post-inflammatory hyperpigmentation in deeper skin tones. Dr. Brown will not perform plasma pen on Fitzpatrick IV, V, or VI — the risk-benefit does not favor the patient. There are better tools for those skin types, and she will recommend them.
Topical numbing is applied for forty-five minutes before. Treatment takes thirty to sixty minutes depending on the area. Most patients get a single session per area; some indications benefit from a second session at twelve weeks.
For broader-area skin tightening on the lower face, neck, or jawline, Dr. Brown will recommend microneedling RF or DermiTight. Those tools cover larger areas more efficiently and with significantly less downtime. Plasma pen is reserved for indications where its precision and depth profile are actually the right match.
What to expect
Day of treatment: Discomfort during treatment despite numbing. Immediately after, the treated area shows a pattern of small dark dots — these are micro-crusts of carbonized tissue. Swelling, particularly around the eyes, is significant in the first 24–48 hours.
Days 1–3: Swelling peaks at 24–72 hours, then begins to settle. Crusts darken and stay firmly attached. Do not pick. Picking produces scarring and pigmentary change.
Days 4–7: Crusts begin to slough on their own. The skin underneath is pink and tender.
Days 7–10: Most crusts have resolved. Pinkness persists and gradually fades over the following weeks. Strict SPF and sun avoidance are required.
Weeks 4–12: Initial tightening is visible by week four. Full collagen response continues to mature through week twelve.
Candidacy
Good candidates have mild upper eyelid hooding, fine lines around the eyes or mouth, or focal laxity in a small area — and accept the 5–10 day downtime. Lighter Fitzpatrick skin types (I–III) are the appropriate population for this device.
Not a candidate with Fitzpatrick IV, V, or VI skin — the pigmentation risk is meaningful and Dr. Brown will not perform the procedure on these skin types. Not a candidate with a history of keloid or hypertrophic scarring. Not a candidate with active acne or skin infection in the treatment field. Not a candidate with pacemakers or implanted electrical devices. Not a candidate if pregnant or nursing.
If the goal is broader-area tightening or you cannot accept visible downtime, plasma pen is not the right tool. Microneedling RF, DermiTight, or a non-ablative laser is the more appropriate option, and Dr. Brown will say so before scheduling.